Today, Sotera Health is providing its full-year 2024 outlook: Net revenues and Adjusted EBITDA growth in the range of 4.0% to 6.0%, Interest Expense in the range of $170 million to $180 million, Tax rate applicable to Adjusted Net Income(1) in the range of 31.5% to 34.5%, Adjusted EPS in the range of $0.67 to $0.75, A weighted-average fully diluted share count in the range of 283 million to 285 million shares, Capital expenditures in the range of $205 million to $225 million
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SHC:
- Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook
- SHC Upcoming Earnings Report: What to Expect?
- Sotera Health Announces Fourth-Quarter and Full-Year 2023 Earnings Release Date
- Tesla downgraded, UPS upgraded: Wall Street’s top analyst calls
- Sotera Health resumed with a Sector Weight at KeyBanc
